Mild Clinical Phenotype in a 12-year-old Boy with Partial Merosin Deficiency and Central and Peripheral Nervous System Abnormalities
Overview
Affiliations
We found partial merosin deficiency in a boy presenting at 12 yr with marked limb weakness and a waddling gait. Magnetic resonance imaging (MRI) showed the characteristic white matter abnormalities of merosin-negative congenital muscular dystrophy. There were also peripheral demyelinating polyneuropathy and evoked potential abnormalities. Unlike classic merosin-negative congenital muscular dystrophy, however, our patient was less hypotonic and weak and was able to achieve independent walking. Both by immunohistochemistry and Western blot merosin was shown to be moderately reduced. By immunostaining the alpha 1 laminin chain was overexpressed and beta 1 laminin chain was reduced. A spectrum of clinical phenotypes is likely to become evident in merosin-deficient patients in relation to the discovery of a range of molecular defects in, and variable expression of, this protein.
LAMA2 Neuropathies: Human Findings and Pathomechanisms From Mouse Models.
Previtali S, Zambon A Front Mol Neurosci. 2020; 13:60.
PMID: 32390798 PMC: 7190814. DOI: 10.3389/fnmol.2020.00060.
Masaki T, Matsumura K J Biomed Biotechnol. 2010; 2010:740403.
PMID: 20625412 PMC: 2896880. DOI: 10.1155/2010/740403.
Court F, Hewitt J, Davies K, Patton B, Uncini A, Wrabetz L J Neurosci. 2009; 29(12):3908-19.
PMID: 19321787 PMC: 2940832. DOI: 10.1523/JNEUROSCI.5672-08.2009.
The congenital muscular dystrophies: recent advances and molecular insights.
Mendell J, Boue D, Martin P Pediatr Dev Pathol. 2006; 9(6):427-43.
PMID: 17163796 PMC: 2855646. DOI: 10.2350/06-07-0127.1.
The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review.
Jones K, MORGAN G, Johnston H, Tobias V, Ouvrier R, Wilkinson I J Med Genet. 2001; 38(10):649-57.
PMID: 11584042 PMC: 1734735. DOI: 10.1136/jmg.38.10.649.